Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells
January 7th, 2019
10.8K views
The goal of this protocol is to identify lymphatic endothelial cell populations within the liver using described markers. We utilize collagenase IV and DNase and a gentle mincing of tissue, combined with flow cytometry, to identify a distinct population of lymphatic endothelial cells.
Overview
This protocol aims to identify lymphatic endothelial cell populations within the liver using specific markers. The method combines collagenase IV and DNase treatment with flow cytometry to isolate distinct lymphatic endothelial cells.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Lymphatic Biology
Background
- Lymphatic endothelial cells (LECs) play a crucial role in various physiological and pathological processes.
- Understanding LEC responses to stimuli can provide insights into disease mechanisms.
- This method allows for the evaluation of LEC phenotype and function at a single-cell level.
- It can be adapted for use with LECs from different tissues, including skin and mammary glands.
Purpose of Study
- To investigate the behavior of liver lymphatic endothelial cells in response to specific stimuli.
- To contribute to the understanding of disease pathogenesis related to lymphatic biology.
- To enable downstream applications following cell sorting.
Methods Used
- Preparation of a single-cell suspension from isolated liver cells.
- Use of collagenase IV and DNase for tissue digestion.
- Flow cytometry for cell identification and sorting.
- Dissection techniques for tissue collection from mouse models.
Main Results
- Successful identification of distinct lymphatic endothelial cell populations.
- Insights into the phenotype and function of liver LECs.
- Potential applications in studying LECs from various tissues.
- Demonstration of the procedure by a trained professional.
Conclusions
- This method provides a valuable tool for studying lymphatic endothelial cells.
- It enhances understanding of liver lymphatic biology and its implications in health and disease.
- Future research can leverage this technique for broader applications in lymphatic studies.
Frequently Asked Questions
What are lymphatic endothelial cells?
Lymphatic endothelial cells (LECs) are specialized cells that line the lymphatic vessels and play a key role in lymphatic function and immune responses.
How does this method benefit research?
This method allows researchers to analyze LECs at a single-cell level, providing insights into their function and role in diseases.
Can this technique be applied to other tissues?
Yes, this method can also be used to evaluate lymphatic endothelial cells from tissues such as skin and mammary glands.
What is the significance of studying liver lymphatic endothelial cells?
Studying liver LECs can help understand their role in liver diseases and overall lymphatic biology.
Who demonstrates this procedure?
The procedure is demonstrated by Jeffrey Finlon, a professional research assistant from the laboratory.
What reagents are used in this protocol?
The protocol utilizes collagenase IV and DNase for tissue digestion.
What is the first step in preparing the tissue?
The first step involves securing the mouse and preparing it for dissection by spraying it with seventy-percent ethanol.
Executive Industry Relevance
This protocol enables single-cell resolution analysis of lymphatic endothelial cells (LECs) from murine liver, addressing a critical gap in tools for studying liver-specific lymphatic biology. By providing a reproducible method to isolate and phenotype rare LEC populations, it supports mechanistic de-risking in target validation efforts related to liver inflammation, immune cell trafficking, and fibrosis. The approach enhances predictive confidence in preclinical models by enabling direct assessment of LEC responses to stimuli in a disease-relevant system.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of lymphatic endothelial cell phenotype and function on a per-cell basis to clarify biological mechanisms in liver pathophysiology.
- Operational Value: Provides a standardized digestion and staining workflow for isolating viable LECs from liver tissue for downstream functional assays.
Screening & Assay Development
- Scientific Value: Generates quantifiable, single-cell readouts of LEC markers (e.g., podoplanin, CD31, CD45, VEGFR3, Prox1) to support assay standardization and reproducibility.
- Operational Value: Prepares validated biological systems suitable for high-throughput screening of compounds modulating lymphatic endothelial cell activity or liver-specific pathways.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant system modeling by enabling isolation of liver LECs to study their role in inflammation, immune surveillance, and fibrosis progression.
- Operational Value: Facilitates translational continuity from discovery to preclinical validation by providing a reusable method for LEC enrichment across multiple experimental conditions.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing to lead identification, particularly for projects focused on liver lymphatic biology, immune modulation, or stromal-targeted therapies.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling phenotypic analysis of liver LECs in response to experimental stimuli.
- Screening: Delivers assay-ready cell suspensions with defined endothelial and lymphatic markers for reliable compound evaluation in 96-well formats.
- Analytics: Enables quantitative flow cytometry readouts to compare LEC frequency, activation state, and co-expression of functional markers across conditions.
- Translational Research: Connects discovery findings to preclinical continuity by allowing isolation of LECs for downstream applications such as transcriptional profiling or functional assays.
- Enterprise Reuse: Establishes a reusable platform for studying lymphatic endothelial cells not only in liver but also in other tissues like skin and mammary gland, maximizing resource efficiency.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity around lymphatic endothelial cell involvement in liver disease processes.
- Operational Value: Enhances reproducibility and scalability of LEC isolation through standardized enzymatic digestion, density gradient separation, and multi-parametric flow cytometry gating.
- Strategic Value: Improves go/no-go decision-making by providing early, human-relevant biological insights into lymphatic-mediated mechanisms in liver pathophysiology.
- Portfolio Impact: Enables risk-adjusted prioritization of targets modulating liver lymphatic function through direct phenotypic assessment of LEC populations.
Implementation Considerations
- Requires expertise in murine tissue dissection, enzymatic digestion, and multi-color flow cytometry with proper compensation controls.
- Dependent on access to flow cytometers, centrifugation equipment, and reagents including collagenase IV, DNase 1, iodixanol, and antibody panels for CD31, CD45, podoplanin, CD16/32, VEGFR3, and Prox1.
- Necessitates cross-team standardization of gating strategies and antibody titration to ensure consistency across laboratories and experimental batches.
- Adaptation to other tissues (e.g., skin, mammary gland) may require optimization of digestion times and straining steps based on tissue density and cellularity.
- Practical limitations include the low frequency and fragility of liver lymphatic endothelial cells, necessitating rapid processing and cold handling to preserve viability and marker integrity.
Biopharma FAQs
Why is proper antibody titration critical for lymphatic endothelial cell identification?
Proper antibody titration ensures specific staining of lymphatic endothelial cell markers like podoplanin and CD31 while minimizing nonspecific binding, which is essential for accurate gating of rare LEC populations in flow cytometry.
How does isolation of CD45 negative CD31 positive cells support target validation in liver lymphatic biology?
Isolating CD45 negative CD31 positive cells enriches for endothelial populations, enabling subsequent discrimination of lymphatic endothelial cells from blood endothelial and hematopoietic cells based on podoplanin and CD16/32 expression.
What quantitative measurements enable assessment of lymphatic endothelial cell purity after sorting?
Co-expression of vascular endothelial growth factor receptor 3 (VEGFR3) and Prospero homeobox protein 1 (Prox1) serves as a quantitative confirmatory measure for validating the purity of sorted liver lymphatic endothelial cell populations.
Why are replication requirements important for cross-functional collaboration in lymphatic endothelial cell studies?
Replication ensures consistent isolation and phenotypic characterization of lymphatic endothelial cells across experiments, enabling reliable data sharing between discovery, preclinical, and translational teams working on liver disease models.
What statistical analysis capabilities are required to compare lymphatic endothelial cell frequencies across experimental conditions?
The method enables generation of percentage-based frequency data for lymphatic endothelial cells within the live, CD45 negative CD31 positive gate, which can be statistically compared using standard parametric or non-parametric tests to evaluate treatment effects.
